TERT and neoplasm: While certain cancer types (ie, HNC and HPBC) exhibited a higher rate of TERT promoter mutations in primary tumor samples compared to metastatic samples, mutations were more prevalent in metastatic samples of melanoma and thyroid cancer compared to primary tumors.